Evacuation of Lobar Intracranial Hemorrhage Using Microsurgical Technique (ELIMINATE)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDr. Michael D Hill

About this trial

ELIMINATE is a cohort study, phase 2A, designed to determine whether a standardized microsurgical procedure to evacuate spontaneous lobar intracranial hemorrhage (ICH) is feasible, safe and surgically efficacious in achieving a postoperative residual ICH volume \<15cc on 24-hour postoperative CT imaging.

Eligibility criteria

Qualifiers

• Adults > 18 years

CT evidence of acute, spontaneous lobar ICH defined as located <1cm from the cortical surface

ICH volume is >30cc but <80cc as measured by (length x width x height)/2

GCS 5-14 at presentation

Disqualifiers

• Underlying secondary etiology (AVM, tumor, etc. if known or identifiable acutely)

Intraventricular extension estimated to involve >50% of the lateral ventricle

Preoperative disability that will affect outcome as measured by modified Rankin Scale score (mRS>1 at baseline)

Individuals presenting with GCS <5 at presentation

Trial design

Treatments tested in this trial

  • Microsurgical hematoma evacuation

Treatment groups

27 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dr. Michael D Hill

Lead sponsor

University of Calgary

Sponsor institution

University of Calgary

Collaborator